Lyme disease treatment market to expand at 6.3% CAGR; Substantial Clinical Research For Effective Treatment To Amplify Market Growth, TMR Study Finds

ALBANY, NY, December 2, 2021 / PRNewswire / – The increasing prevalence of Lyme disease in developed countries that receive funding from non-medical organizations to develop the treatment is fueling the growth of the Lyme disease treatment market. Lyme disease is the most common vector-borne disease in the United States with nearly half a million cases reported each year. According to the Centers for Disease Control and Prevention, 20,000 to 30,000 confirmed cases of Lyme disease are reported in the United States each year. The number of Lyme disease cases has also increased steadily in Europe, reports the World Health Organization.

Lyme disease is prevalent in humans and animals, and growing affection towards pets is leading to increased transmission of Lyme disease. Lyme disease is transmitted by bacteria and transmitted to humans through the bite of infected blacklegged ticks. Headaches, fever, and rashes are common symptoms of Lyme disease, which can spread to the heart, joints, and neurotic system if not treated in time.

Request Lyme Disease Treatment Market Research Report Brochure –

The factors are assessed for the Lyme disease treatment market, which is expected to reach US $ 3 billion by 2031.

Lyme Disease Treatment Market – Key Findings of the Report

Initiatives to develop a new line of treatment for the early detection of ongoing diseases

Clinical research such as that based on a novel cytokine immunoassay for earlier and improved examination of Lyme disease is underway in the Lyme disease treatment market. This involves the use of advanced technologies for rapid point-of-care treatment of Lyme disease. New ways to identify Lyme disease, early stage examination, precise disease staging, and indications for successful treatment are other goals of clinical research initiatives in the disease treatment market. of Lyme.

Request for Analysis of the Impact of COVID-19 on the Lyme Disease Treatment Market –

Clinical trials funded by medical organizations to study the effectiveness of prolonged antibiotic therapy for the treatment of Lyme disease are underway. Nonetheless, innovations for simple and effective Lyme disease treatments have been adopted by major players in the Lyme disease treatment market for the enhancement of the disease treatment portfolio. For example, initiatives by the National Institutes of Health in several areas of research for the treatment of Lyme disease show that most people recover within weeks of completing oral therapy when they are treated soon after symptoms appear.

Risk of secondary disease mortality in dogs receives attention

The United States has a high number of Lyme disease cases in dogs, while other geographies are expected to see more ticks carrying bacteria in dogs. Symptoms of Lyme disease also vary in animals without symptoms.

TMR offers customized market research services that help clients gain insight into their required business scenario when syndicated solutions are not enough, Custom Research Request –

Loss of appetite, pain or swelling, fever and swollen lymph joints are the first signs of lymphatic disease in animals, which, if left untreated, can lead to serious damage to the heart. , nervous system or kidneys. Lyme disease affecting the organs is the second most common symptom in dogs and is usually fatal. This explains the attention paid to Lyme disease treatment in pet owners.

Lyme Disease Treatment Market – Growth Drivers

  • Rising Pet Ownership and Spending on Veterinary Care Boost Lyme Disease Treatment Market
  • Clinical research supported by government organizations and large companies to develop treatment for Lyme disease prevalent in humans and animals is fueling growth in Lyme disease treatment market

Lyme Disease Treatment Market – Key Players

Some key players operating in the Lyme disease treatment market are GlaxoSmithKline plc, Novartis AG, Almirall LLC, Boehringer Ingelheim International GmbH, Lupine Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Orion Corporation, F. Hoffmann-La Roche Ltd ., Mayne Pharma, Galderma Laboratories LP, Chartwell Pharmaceuticals and Perrigo Company plc.

Buy Lyme Disease Treatment Market Report

The Lyme disease treatment market is segmented as follows;

Lyme Disease Treatment Market, By Treatment Type

  • Medication
    • Antibiotics
      • Cephalosporin
      • Tetracycline
      • Macrolides
      • Others
    • NSAIDs
    • Others
  • Tick ​​removal

Lyme Disease Treatment Market, By Bacteria Type

  • Borrelia burgdorferi
  • Borrelia mayonii
  • Borrelia afzelii
  • Borrelia garinii
  • Others

Lyme Disease Treatment Market, By Administration

Lyme Disease Treatment Market, By Application

Lyme Disease Treatment Market, By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Lyme Disease Treatment Market, By Region

  • North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

The modernization of healthcare in terms of infrastructure and services has pushed the healthcare sector to new heights, Stay up to date with Latest research reports on the health industry through market research on transparency:

Von Willebrand Disease Treatment Market: Research and development activities are expected to play a significant role in increasing the growth of the global Von Willebrand Disease Treatment market during the assessment period. The arrival of new therapies and treatment for von Willebrand disease, as a result of research programs and initiatives, is expected to significantly boost the global von Willebrand disease treatment market.

FFPE Tissue Samples Market: This report analyzes the current scenario and future prospects of the global FFPE Tissue Samples Market. FFPE is a form of preparation and storage of biopsy specimens that assists in diagnostic / drug development, experimental research, and examination.

Herbal Vaccines Market: Global Herbal Vaccines Market for the historical period of 2017-2019 and forecast period of 2021-2031, increasing incidence of infections, government initiatives for expansion of Vaccine coverage and government funding for vaccine development are expected to boost the global herbal vaccine market in the near future

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our proprietary blend of quantitative forecasting and trend analysis provides forward-looking information to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to collect and analyze information.

Our data repository is continually updated and reviewed by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analytical capacity, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

For more information on research on major industries, visit our YouTube channel and click Subscribe for the future update –

Sir. Rohit Bhisey
Market research on transparency
State Tower,
90 State Street,
Office 700,
Albany NY – 12207
United States
United States – Canada Toll Free: 866-552-3453
E-mail: [email protected]
Follow us: Twitter | LinkedIn
Browse public relations –

SOURCE Transparency Market Research

Source link

About Terry Gongora

Check Also

Pharmacists are also facing pandemic burnout

Everyone knows doctors and nurses are exhausted by COVID-19, facing staff shortages, full emergency rooms …